paroxetine has been researched along with s20098 in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| D'haenen, H; Hale, A; Lôo, H | 1 |
| Burrows, GD; Hindmarch, I; Kennedy, SH; Lejoyeux, M; Montgomery, SA | 1 |
| Bosker, FJ; den Boer, JA; Meesters, Y | 1 |
| Alonso, S; Gabriel, C; Matias, J; Mocaër, E; Montejo, AL; Naval, S; Paniagua, G; Parra, DG; Portolés, A; Prieto, N; Terleira, A | 1 |
| Humpston, CS; Robinson, ES; Wood, CM | 1 |
| de Bodinat, C; Lejoyeux, M; Matharan, S | 1 |
| Chang, CC; Chang, HA; Huang, SY; Kao, LC; Kuo, TB; Tzeng, NS; Yeh, TC | 1 |
| Gao, KR; Li, HF; Shen, YF; Yu, H; Yu, YM | 1 |
| Holper, L | 1 |
| Bulmus, O; Canpolat, S; Gulcu Bulmus, F; Kelestimur, H; Sahin, Z; Serhatlioglu, I | 1 |
| Cui, P; Hao, L; He, X; Jia, Y; Liang, Z; Tong, B; Yang, F; Yuan, J; Zhao, L; Zhu, R | 1 |
7 trial(s) available for paroxetine and s20098
| Article | Year |
|---|---|
Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study.
Topics: Acetamides; Adult; Antidepressive Agents; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Serotonin Antagonists; Treatment Outcome | 2002 |
Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.
Topics: Acetamides; Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paroxetine; Placebos; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 2004 |
Better sexual acceptability of agomelatine (25 and 50 mg) compared with paroxetine (20 mg) in healthy male volunteers. An 8-week, placebo-controlled study using the PRSEXDQ-SALSEX scale.
Topics: Acetamides; Adult; Antidepressive Agents, Second-Generation; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Humans; Hypnotics and Sedatives; Male; Paroxetine; Psychometrics; Severity of Illness Index; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Time Factors; Young Adult | 2010 |
How to switch to agomelatine after an unsuccessful try with paroxetine or venlafaxine.
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Substitution; Female; Humans; Male; Middle Aged; Paroxetine; Venlafaxine Hydrochloride | 2015 |
Heart rate variability in major depressive disorder and after antidepressant treatment with agomelatine and paroxetine: Findings from the Taiwan Study of Depression and Anxiety (TAISDA).
Topics: Acetamides; Adult; Aged; Antidepressive Agents; Blood Pressure; Cardiovascular Agents; Case-Control Studies; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Rest; Severity of Illness Index; Taiwan; Young Adult | 2016 |
Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents; Asian People; China; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Young Adult | 2018 |
Agomelatine might be more appropriate for elderly, depressed, type 2 diabetes mellitus patients than paroxetine/fluoxetine.
Topics: Acetamides; Adult; Aged; Aging; Antidepressive Agents, Second-Generation; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Paroxetine | 2021 |
5 other study(ies) available for paroxetine and s20098
| Article | Year |
|---|---|
Clinical efficacy of agomelatine in depression: the evidence.
Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents; Controlled Clinical Trials as Topic; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drugs, Investigational; Humans; Middle Aged; Multicenter Studies as Topic; Paroxetine; Treatment Outcome | 2006 |
Agomelatine: new drug. Adverse effects and no proven efficacy.
Topics: Acetamides; Animals; Antidepressive Agents; Bias; Carcinogens; Clinical Trials as Topic; Cyclohexanols; Depression; Depressive Disorder; Double-Blind Method; Drug Approval; Europe; Fluoxetine; Humans; Hypnotics and Sedatives; Melatonin; Paroxetine; Psychiatric Status Rating Scales; Receptors, Melatonin; Recurrence; Selective Serotonin Reuptake Inhibitors; Suicide; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Investigating the roles of different monoamine transmitters and impulse control using the 5-choice serial reaction time task.
Topics: Acetamides; Adrenergic alpha-2 Receptor Antagonists; Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Choice Behavior; Cyclobutanes; Cyclohexanols; Fluoxetine; Hypnotics and Sedatives; Idazoxan; Impulsive Behavior; Male; Norepinephrine; Paroxetine; Rats; Reaction Time; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2013 |
Combining threshold analysis and GRADE to assess sensitivity to bias in antidepressant treatment recommendations adjusted for depression severity.
Topics: Acetamides; Adult; Amitriptyline; Antidepressive Agents; Bayes Theorem; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Network Meta-Analysis; Paroxetine; Publication Bias; Reproducibility of Results; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride | 2020 |
Kisspeptin and RF9 prevent paroxetine-induced changes in some parameters of seminal vesicle fluid in the male rats.
Topics: Acetamides; Adamantane; Animals; Dipeptides; Drug Evaluation, Preclinical; Kisspeptins; Male; Paroxetine; Random Allocation; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Semen | 2020 |